Degron Therapeutics Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Degron Therapeutics is a drug discovery platform. They provide the discovery and development of a new class of targeted protein degradation therapeutics and small molecule molecular glue degrader drugs. Degron Therapies aspires to be a global leader in the discovery and development of small molecule molecular glue degrader (MGD) medicines, a new class of targeted protein degradation therapeutics. Degron has assembled a team of world-class executives and scientific leaders to apply its scientific

Elite School Alumni
Company Highlights
Year Founded

2021

icon-altEmployees

15

Location (HQ)

USA

Since Last Funding

10 months

Monthly Website Visitors

803

icon-altTotal Investment Amt

$54M

icon-altMoM Headcount Growth

7.09%

icon-altYoY Headcount Growth

15.27%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Health Care

Biotechnology Research

Pharmaceuticals

Oncology